My Legacy Advisors, LLC Edwards Lifesciences Corp Transaction History

My Legacy Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 20, 2023	BUY	$69.28 - $93.38 $6,027 - $8,124	87 Added 1.03%	8,552 $592,000
Q2 2023 Jul 14, 2023	SELL	$81.41 - $94.33 $13,269 - $15,375	-163 Reduced 1.89%	8,465 $798,000
Q1 2023 Apr 11, 2023	SELL	$74.26 - $84.51 $7,797 - $8,873	-105 Reduced 1.2%	8,628 $713,000
Q4 2022 Feb 07, 2023	SELL	$68.3 - $87.44 $2,390 - $3,060	-35 Reduced 0.4%	8,733 $651,000
Q3 2022 Oct 17, 2022	BUY	$82.37 - $107.29 $24,299 - $31,650	295 Added 3.48%	8,768 $723,000
Q2 2022 Jul 12, 2022	SELL	$86.5 - $128.27 $15,743 - $23,345	-182 Reduced 2.1%	8,473 $821,000
Q1 2022 Apr 07, 2022	BUY	$101.96 - $128.34 $882,463 - $1.11 Million	8,655 New	8,655 $1.02 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of My Legacy Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on My Legacy Advisors, LLC with notifications on news.